These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1591727)

  • 1. Drug transport mechanisms in HL60 cells isolated for resistance to adriamycin: evidence for nuclear drug accumulation and redistribution in resistant cells.
    Marquardt D; Center MS
    Cancer Res; 1992 Jun; 52(11):3157-63. PubMed ID: 1591727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
    Gollapudi S; Gupta S
    Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
    Politi PM; Sinha BK
    Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
    Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
    Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein.
    Marquardt D; McCrone S; Center MS
    Cancer Res; 1990 Mar; 50(5):1426-30. PubMed ID: 1967979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Deffie AM; Alam T; Seneviratne C; Beenken SW; Batra JK; Shea TC; Henner WD; Goldenberg GJ
    Cancer Res; 1988 Jul; 48(13):3595-602. PubMed ID: 2897875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of multidrug resistance in HL60 cells: evidence that a surface membrane protein distinct from P-glycoprotein contributes to reduced cellular accumulation of drug.
    McGrath T; Center MS
    Cancer Res; 1988 Jul; 48(14):3959-63. PubMed ID: 2898287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
    Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
    Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug.
    Marsh W; Sicheri D; Center MS
    Cancer Res; 1986 Aug; 46(8):4053-7. PubMed ID: 2425939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin resistance in HL60 cells and accompanying modification of a surface membrane protein contained in drug-sensitive cells.
    Marsh W; Center MS
    Cancer Res; 1987 Oct; 47(19):5080-6. PubMed ID: 3621192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy.
    Gervasoni JE; Fields SZ; Krishna S; Baker MA; Rosado M; Thuraisamy K; Hindenburg AA; Taub RN
    Cancer Res; 1991 Sep; 51(18):4955-63. PubMed ID: 1680024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.
    Inaba M; Kobayashi H; Sakurai Y; Johnson RK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2200-3. PubMed ID: 445418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
    Abbaszadegan MR; Cress AE; Futscher BW; Bellamy WT; Dalton WS
    Cancer Res; 1996 Dec; 56(23):5435-42. PubMed ID: 8968098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-resistance to rhodamine 123 in Adriamycin- and daunorubicin-resistant Friend leukemia cell variants.
    Tapiero H; Munck JN; Fourcade A; Lampidis TJ
    Cancer Res; 1984 Dec; 44(12 Pt 1):5544-9. PubMed ID: 6498816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of multidrug resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumor cells.
    Keizer HG; Schuurhuis GJ; Broxterman HJ; Lankelma J; Schoonen WG; van Rijn J; Pinedo HM; Joenje H
    Cancer Res; 1989 Jun; 49(11):2988-93. PubMed ID: 2566376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein.
    Krishnamachary N; Center MS
    Cancer Res; 1993 Aug; 53(16):3658-61. PubMed ID: 8101765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression.
    Slapak CA; Daniel JC; Levy SB
    Cancer Res; 1990 Dec; 50(24):7895-901. PubMed ID: 1979251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of vacuolar H+-ATPase impair the preferential accumulation of daunomycin in lysosomes and reverse the resistance to anthracyclines in drug-resistant renal epithelial cells.
    Ouar Z; Bens M; Vignes C; Paulais M; Pringel C; Fleury J; Cluzeaud F; Lacave R; Vandewalle A
    Biochem J; 2003 Feb; 370(Pt 1):185-93. PubMed ID: 12435274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.
    Drew L; Groome N; Warr JR; Rumsby MG
    Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells.
    Lutzky J; Astor MB; Taub RN; Baker MA; Bhalla K; Gervasoni JE; Rosado M; Stewart V; Krishna S; Hindenburg AA
    Cancer Res; 1989 Aug; 49(15):4120-5. PubMed ID: 2568167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.